De Luca LM - Search Results

1

Considerations in developing successful, population-based molecular screening and prevention of lung cancer.

Mulshine JL, De Luca LM, Dedrick RL, Tockman MS, Webster R, Placke ME. Mulshine JL, et al. Among authors: de luca lm. Cancer. 2000 Dec 1;89(11 Suppl):2465-7. doi: 10.1002/1097-0142(20001201)89:11+<2465::aid-cncr24>3.3.co;2-y. Cancer. 2000. PMID: 11147628 Review.

2

Moving to the routine management of pre symptomatic lung cancer.

Mulshine JL, Hong S, Martínez A, Tauler J, Avis I, Tockman MS, De Luca LM, Placke ME, Cuttitta F. Mulshine JL, et al. Among authors: de luca lm. Lung Cancer. 2001 Dec;34 Suppl 2:S1-5. doi: 10.1016/s0169-5002(01)00401-9. Lung Cancer. 2001. PMID: 11720735

3

Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptors.

Wang DL, Marko M, Dahl AR, Engelke KS, Placke ME, Imondi AR, Mulshine JL, De Luca LM. Wang DL, et al. Among authors: de luca lm. Clin Cancer Res. 2000 Sep;6(9):3636-45. Clin Cancer Res. 2000. PMID: 10999756

4

Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study.

Dahl AR, Grossi IM, Houchens DP, Scovell LJ, Placke ME, Imondi AR, Stoner GD, De Luca LM, Wang D, Mulshine JL. Dahl AR, et al. Among authors: de luca lm. Clin Cancer Res. 2000 Aug;6(8):3015-24. Clin Cancer Res. 2000. PMID: 10955779

5

Differences in uptake and metabolism of retinoic acid between estrogen receptor-positive and -negative human breast cancer cells.

Okamoto K, Andreola F, Chiantore MV, Dedrick RL, De Luca LM. Okamoto K, et al. Among authors: de luca lm. Cancer Chemother Pharmacol. 2000;46(2):128-34. doi: 10.1007/s002800000125. Cancer Chemother Pharmacol. 2000. PMID: 10972482

6

Retinoid status controls the appearance of reserve cells and keratin expression in mouse cervical epithelium.

Darwiche N, Celli G, Sly L, Lancillotti F, De Luca LM. Darwiche N, et al. Among authors: de luca lm. Cancer Res. 1993 May 15;53(10 Suppl):2287-99. Cancer Res. 1993. PMID: 7683571

7

Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells.

Zhu WY, Jones CS, Amin S, Matsukuma K, Haque M, Vuligonda V, Chandraratna RA, De Luca LM. Zhu WY, et al. Among authors: de luca lm. Cancer Res. 1999 Jan 1;59(1):85-90. Cancer Res. 1999. PMID: 9892191

8

beta-Carotene fails to act as a tumor promoter, induces RAR expression, and prevents carcinoma formation in a two-stage model of skin carcinogenesis in male Sencar mice.

Ponnamperuma RM, Shimizu Y, Kirchhof SM, De Luca LM. Ponnamperuma RM, et al. Among authors: de luca lm. Nutr Cancer. 2000;37(1):82-8. doi: 10.1207/S15327914NC3701_11. Nutr Cancer. 2000. PMID: 10965524

9

Human breast cancer MDA-MB-231 cells fail to express the neurofibromin protein, lack its type I mRNA isoform and show accumulation of P-MAPK and activated Ras.

Ogata H, Sato H, Takatsuka J, De Luca LM. Ogata H, et al. Among authors: de luca lm. Cancer Lett. 2001 Oct 30;172(2):159-64. doi: 10.1016/s0304-3835(01)00648-6. Cancer Lett. 2001. PMID: 11566491

10

Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors.

Darwiche N, Celli G, Tennenbaum T, Glick AB, Yuspa SH, De Luca LM. Darwiche N, et al. Among authors: de luca lm. Cancer Res. 1995 Jul 1;55(13):2774-82. Cancer Res. 1995. PMID: 7540949

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters